NEW YORK, June 12, 2019 /PRNewswire/ -- WeissLaw
LLP is investigating possible breaches of fiduciary duty and
other violations of law by the Board of Directors of Vical
Incorporated ("VICL" or the "Company") (NASDAQ: VICL) in connection
with the proposed acquisition of the Company by Brickell Biotech,
Inc.
If you are a shareholder of VICL who wishes to
discuss the investigation or have any questions about this notice
and your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888)593-4771
stockinfo@weisslawllp.com
Or visit our website
http://www.weisslawllp.com/vical-incorporated/
Or follow us on Twitter
@MarketsAlert
WeissLaw is investigating whether VICL's Board acted to maximize
shareholder value prior to entering into the agreement.
Notably, at close of the transaction, VICL shareholders will own
only 40% of the combined company.
WeissLaw is also investigating whether VICL's Board conducted a
fair process in agreeing to the proposed merger, whether the
proposed merger undervalues the Company, and whether all material
information related to the proposed merger is fully and fairly
disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-vical-incorporated-acquisition-300866502.html
SOURCE WeissLaw LLP
